bioRxivGenomicsPreprint
Human and bats genome robustness under COSMIC mutational signatures
Joon-Hyun SongiD, Ying ZengiD, Liliana M. DávalosiD, Thomas MacCarthyiD, Mani LarijaniiD, Mehdi DamaghiiD
Abstract
Carcinogenesis is an evolutionary process, and mutations can fix the selected phenotypes in selective microenvironments. Both normal and neoplastic cells are robust to the mutational stressors in the microenvironment to the extent that secure their fitness. To test the robustness of genes under a range of mutagens, we developed a sequential mutation simulator, Sinabro, to simulate single base substitution under a given mutational process. Then, we developed a pipeline to measure the robustness of genes and cells under those mutagenesis processes. We discovered significant human genome robustness to the APOBEC mutational signature SBS2, which is associated with viral defense mechanisms and is implicated in cancer. Robustness evaluations across over 70,000 sequences against 41 signatures showed higher resilience under signatures predominantly causing C-to-T (G-to-A) mutations. Principal component analysis indicates the GC content at the codons wobble position significantly influences robustness, with increased resilience noted under transition mutations compared to transversions. Then, we tested our results in bats at extremes of the lifespan-to-mass relationship and found the long-lived bat is more robust to APOBEC than the short-lived one. By revealing robustness to APOBEC ranked highest in human (and bats with much more than number of APOBEC) genome, this work bolsters the key potential role of APOBECs in aging and cancer, as well as evolved countermeasures to this innate mutagenic process. It also provides the baseline of the human and bat genome robustness under mutational processes associated with aging and cancer. HighlightsO_LISinabro, the sequential mutation simulator, facilitates measuring the robustness of human protein-coding sequences under all COSMIC mutational signatures. C_LIO_LIRobustness under APOBEC mutational signatures showed the largest mean and standard deviation in the human genome. C_LIO_LIRobustness to mutational signatures analysis reveals the role of APOBECs is complementary to cancer in the evolvability of cancer cells in later stages. C_LIO_LIPrincipal component analysis indicates that the GC content at the codons wobble position significantly influences robustness. C_LIO_LIA long-lived bat (Myotis myotis) has higher robustness to APOBECs than a short-lived one (Molossus molossus) than humans. C_LI
- organism: human
- organism: bacteria (other)
- assay: whole-genome sequencing
- research focus: benchmarking
- research focus: variant effect prediction
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer
Yoo-Ah Kim, Damian Wójtowicz, … Teresa M. Przytycka·Genome MedicinePeer-reviewed·May 29, 2020
- APOBEC3A, not APOBEC3B, drives deaminase mutagenesis in human gastric epithelium
Yohan An, Ji‐Hyun Lee, … Young Seok Ju·bioRxiv·Oct 28, 2024
- The cytidine deaminase APOBEC3G drives cancer mutagenesis and clonal evolution in bladder cancer
Weisi Liu, Kevin P. Newhall, … Bishoy M. Faltas·bioRxiv·Sep 5, 2022
- APOBEC3A Catalyzes Mutation and Drives Carcinogenesis In Vivo
E. Law, R. Levin-Klein, … R. Harris·bioRxiv·Dec 27, 2019
- The APOBEC3A deaminase drives episodic mutagenesis in cancer cells
M. Petljak, K. Chu, … J. Maciejowski·bioRxiv·Feb 14, 2021
- Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer
M. A. Carpenter, N. A. Temiz, … R. S. Harris·bioRxiv·Apr 26, 2022